Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2012
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trialGlenn M Chertow, Ricardo Correa-Rotter, Geoffrey A Block, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2013
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trialPatrick S Parfrey, Glenn M Chertow, Geoffrey A Block, et al.
The New England Journal of Medicine|November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis, Glenn M Chertow, Geoffrey A Block, et al.
Journal of the American Heart Association|November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trialDavid C Wheeler, Gerard M London, Patrick S Parfrey, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2019
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot TrialKalani L Raphael, Tamara Isakova, Joachim H Ix, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 30, 2020
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKDAnand Srivastava, Xuan Cai, Jungwha Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2019
Serum Calcification Propensity and Clinical Events in CKDJoshua D Bundy, Xuan Cai, Rupal C Mehta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2019
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) StudyJoshua D Bundy, Xuan Cai, Julia J Scialla, et al.
Kidney360|April 4, 2022
Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE TrialAnn A Wang, Xuan Cai, Anand Srivastava, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2012
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trialGlenn M Chertow, Ricardo Correa-Rotter, Geoffrey A Block, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2013
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trialPatrick S Parfrey, Glenn M Chertow, Geoffrey A Block, et al.
The New England Journal of Medicine|November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis, Glenn M Chertow, Geoffrey A Block, et al.
Journal of the American Heart Association|November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trialDavid C Wheeler, Gerard M London, Patrick S Parfrey, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2019
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot TrialKalani L Raphael, Tamara Isakova, Joachim H Ix, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 30, 2020
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKDAnand Srivastava, Xuan Cai, Jungwha Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2019
Serum Calcification Propensity and Clinical Events in CKDJoshua D Bundy, Xuan Cai, Rupal C Mehta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2019
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) StudyJoshua D Bundy, Xuan Cai, Julia J Scialla, et al.
Kidney360|April 4, 2022
Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE TrialAnn A Wang, Xuan Cai, Anand Srivastava, et al.
Pageof 12